|
1
|
Aird WC: Phenotypic heterogeneity of the
endothelium: II. Representative vascular beds. Circ Res.
100:174–190. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cooper DL, Carmical JA, Panus PC and
Harirforoosh S: Formulation andin vitro evaluation of niacin-loaded
nanoparticles to reduce prostaglandinmediated vasodilatory
flushing. Eur Rev Med Pharmacol Sci. 19:3977–3988. 2015.PubMed/NCBI
|
|
3
|
Boller YC, Brandes LM, Russell RL, Lin ZP,
Patierno SR and Kennedy KA: Prostaglandin A1 inhibits
stress-induced NF-kappaB activation and reverses resistance to
topoisomerase II inhibitors. Oncol Res. 12:383–395. 2000.PubMed/NCBI
|
|
4
|
Hu K, Liu Z and Liu D: Triptolide inhibits
vascular endothelial growth factor expression and production by
endothelial cells. Zhonghua Yi Xue Za Zhi. 81:1106–1109. 2001.(In
Chinese). PubMed/NCBI
|
|
5
|
Popovic JK, Grujic Z, Grujic I, Bogavac M,
Celic D, Popovic KJ, Jakovljevic A and Popovic DJ: Prostaglandin
E2, trace elements and levels of oxidative processes in spontaneous
miscarriages. Eur Rev Med Pharmacol Sci. 20:4786–4790.
2016.PubMed/NCBI
|
|
6
|
Grandmougin D, Vanhuyse F, Fiore A,
Delolme MC, Liu Y, Laurent N, Bertram M, Folliguet T, Tran N and
Maureira JP: Effects of the self-myocardial retroperfusion with
aortic-coronary sinus shunt on cardiac output and ischemic events
in high-risk patients undergoing OPCAB surgery. J Cardiovasc Surg
(Torino). 56:929–937. 2015.PubMed/NCBI
|
|
7
|
Li X, Liu M, Sun R, Zeng Y, Chen S and
Zhang P: Protective approaches against myocardial ischemia
reperfusion injury. Exp Ther Med. 12:3823–3829. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Klingel K, Rieger P, Mall G, Selinka HC,
Huber M and Kandolf R: Visualization of enteroviral replication in
myocardial tissue by ultrastructural in situ hybridization:
Identification of target cells and cytopathic effects. Lab Invest.
78:1227–1237. 1998.PubMed/NCBI
|
|
9
|
Youle RJ and Strasser A: The Bcl-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hsieh PC, Davis ME, Lisowski LK and Lee
RT: Endothelial-cardiomyocyte interactions in cardiac development
and repair. Annu Rev Physiol. 68:51–66. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huber SA, Haisch C and Lodge PA:
Functional diversity in vascular endothelial cells: Role in
coxsackievirus tropism. J Virol. 64:4516–4522. 1990.PubMed/NCBI
|
|
12
|
Salakou S, Kardamakis D, Tsamandas AC,
Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos
DS, Papapetropoulos T, Petsas T, et al: Increased Bax/Bcl-2 ratio
up-regulates caspase-3 and increases apoptosis in the thymus of
patients with myasthenia gravis. In Vivo. 21:123–132.
2007.PubMed/NCBI
|
|
13
|
Gioacchini FM, Alicandri-Ciufelli M,
Rubini C, Magliulo G and Re M: Prognostic value of Bcl-2 expression
in squamous cell carcinoma of the larynx: A systematic review. Int
J Biol Markers. 30:e155–e160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Choi JE, Woo SM, Min KJ, Kang SH, Lee SJ
and Kwon TK: Combined treatment with ABT-737 and VX-680 induces
apoptosis in Bcl-2- and c-FLIP-overexpressing breast carcinoma
cells. Oncol Rep. 33:1395–1401. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gharbi S, Garzón B, Gayarre J, Timms J and
Pérez-Sala D: Study of protein targets for covalent modification by
the antitumoral and anti-inflammatory prostaglandin PGA1: Focus on
vimentin. J Mass Spectrom. 42:1474–1484. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gayarre J, Stamatakis K, Renedo M and
Pérez-Sala D: Differential selectivity of protein modification by
the cyclopentenone prostaglandins PGA1 and
15-deoxy-Delta12,14-PGJ2: Role of glutathione. FEBS Lett.
579:5803–5808. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Elia G, Polla B, Rossi A and Santoro MG:
Induction of ferritin and heat shock proteins by prostaglandin A1
in human monocytes. Evidence for transcriptional and
post-transcriptional regulation. Eur J Biochem. 264:736–745. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qiu D and Kao PN: Immunosuppressive and
anti-inflammatory mechanisms of triptolide, the principal active
diterpenoid from the Chinese medicinal herb Tripterygium
wilfordii Hook. f. Drugs R D. 4:1–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu H, Liu ZH, Chen ZH, Yang JW and Li LS:
Triptolide: A potent inhibitor of NF-kappa B in T-lymphocytes. Acta
Pharmacol Sin. 21:782–786. 2000.PubMed/NCBI
|
|
20
|
Jiang XH, Wong BC, Lin MC, Zhu GH, Kung
HF, Jiang SH, Yang D and Lam SK: Functional p53 is required for
triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB
activation in gastric cancer cells. Oncogene. 20:8009–8018. 2001.
View Article : Google Scholar : PubMed/NCBI
|
